Literature DB >> 27303187

The Effect of 0.5% Sodium Tetradecyl Sulfate on a Venous Lake Lesion.

Suck Joon Jung1, Young Ju Seo1, Eun Ju Park1, Chul Woo Kim1, Hee Jin Cho1, Kwang Ho Kim1, Kwang Joong Kim1.   

Abstract

BACKGROUND: A venous lake lesion is a venous ectasia that occurs on the exposed skin of elderly people. Although a number of therapies such as surgical excision, laser therapy, infrared coagulation, cryotherapy and sclerotherapy have been used to treat venous lakes, there is no guideline for treating this lesion.
OBJECTIVE: The purpose of this study was to determine whether 0.5% sodium tetradecyl sulfate (STS) is effective for the treatment of venous lake lesions.
METHODS: Twelve patients with venous lake lesions were enrolled In this study. After proper antiseptic preparation, 0.5% STS was slowly injected into each subject's lesion, and this was followed by immediate compression for 10 minutes.
RESULTS: After treatment, all of the patients' lesions cleared completely. The average number of treatments was 2.15±1.28. Two patients experienced mild side effects such as light pain and paresthesia, and these soon disappeared. There were no serious side effects reported during treatment. The mean follow up period was 29.58±13.48 months.
CONCLUSION: We have demonstrated that sclerotherapy with 0.5% STS was quite effective for treating venous lake lesions, and this treatment caused no serious adverse effects.

Entities:  

Keywords:  Sclerotherapy; Sodium tetradecyl sulfate; Venous lake

Year:  2008        PMID: 27303187      PMCID: PMC4903974          DOI: 10.5021/ad.2008.20.4.179

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  20 in total

1.  Treatment of telangiectases and other benign vascular lesions with the 577 nm pulsed dye laser.

Authors:  E Gonzalez; R W Gange; K T Momtaz
Journal:  J Am Acad Dermatol       Date:  1992-08       Impact factor: 11.527

2.  Venous lakes.

Authors:  W B BEAN; J R WALSH
Journal:  AMA Arch Derm       Date:  1956-11

3.  Venous lakes (Bean-Walsh) of the lips--treatment experience with the argon laser and 18 months follow-up.

Authors:  R A Neumann; R M Knobler
Journal:  Clin Exp Dermatol       Date:  1990-03       Impact factor: 3.470

4.  Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.

Authors:  Alessandro Frullini; Attilio Cavezzi
Journal:  Dermatol Surg       Date:  2002-01       Impact factor: 3.398

5.  [Oral venous lakes: a clinicopathologic analysis of 20 cases].

Authors:  Jingqiu Bu; Huaiyin Shi; Min Hu; Hongchen Liu
Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi       Date:  2002-01

6.  Venous lakes: a report of 32 cases treated by carbon dioxide laser vaporization.

Authors:  Jesús del Pozo; Carmen Peña; Jesús García Silva; Jose Jaime Goday; Eduardo Fonseca
Journal:  Dermatol Surg       Date:  2003-03       Impact factor: 3.398

Review 7.  Treatment of facial telangiectasia with sclerotherapy, laser surgery, and/or electrodesiccation: a review.

Authors:  M P Goldman; R A Weiss; H J Brody; W P Coleman; R E Fitzpatrick
Journal:  J Dermatol Surg Oncol       Date:  1993-10

8.  Sclerosing agents in the treatment of telangiectasia. Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model.

Authors:  M P Goldman; R P Kaplan; L N Oki; P A Cavender; R A Strick; R G Bennett
Journal:  Arch Dermatol       Date:  1987-09

Review 9.  Advances in sclerotherapy.

Authors:  R A Weiss; M P Goldman
Journal:  Dermatol Clin       Date:  1995-04       Impact factor: 3.478

10.  Venous lake of the lip treated with a sclerosing agent: report of two cases.

Authors:  Hung-Wen Kuo; Chih-Hsun Yang
Journal:  Dermatol Surg       Date:  2003-04       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.